MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Isolated craniocervical dystonia without neuropsychiatric manifestations associated with NMDA-receptor antibodies

    S. Waller, L. Williams, A. Lee, MW. Lin, H. Morales-Briceno, V. Fung (Westmead, Australia)

    Objective: N-methyl-D-aspartate receptor (NMDAR) encephalitis classically spans neuropsychiatric disturbance, autonomic dysfunction and salient movement disorders. Attenuated presentations are increasingly recognised; however, presentations with an isolated…
  • 2022 International Congress

    Pallidal firing rate and alpha oscillations correlate with the severity of clinical symptoms in patients with dystonia

    U. Semenova, R. Medvednik, A. Tomskiy, V. Popov, A. Sedov (Moscow, Russian Federation)

    Objective: To examined how pallidal activity correlates with symptom severity across dystonic patients. Background: The internal segment of globus pallidus (GPi) is the most common…
  • 2022 International Congress

    Clinical Manifestations of Autonomic Dysfunction in Parkinsonism Assessed by COMPASS-31 Questionnaire

    D. Tunjungsari, A. Tiksnadi (Jakarta, Indonesia)

    Objective: The study aims to describe the manifestations of autonomic disorders, including symptoms and related factors, in Parkinsonism cases ​​​​​​​ Background: Parkinsonism is a progressive neurodegenerative…
  • 2022 International Congress

    Autonomic dysfunction in p.A53T SNCA PD vs GBA PD and idiopathic PD : A study in a Greek population.

    AM. Simitsi, P. Kokotis, C. Koros, C. Bougea, N. Papagiannakis, R. Antonelou, I. Pachi, D. Papadimitrioy, M. Stamelou, L. Stefanis (ATHENS, Greece)

    Objective: Τo assess whether autonomic dysfunction occurs in p.A53T SNCA mutation carriers manifesting Parkinson’s Disease (A53T-PD), using both subjective and objective measures and to compare…
  • 2022 International Congress

    Altered Brain Connectivity in Hyperkinetic Movement Disorders: Systematic Review of Resting-State fMRI Studies

    R. Marapin, H. vd Horn, A. vd Stouwe, J. Dalenberg, B. de Jong, M. Tijssen (Groningen, Netherlands)

    Objective: Providing a comprehensive literature review of resting-state brain connectivity alterations using resting-state fMRI (rs-fMRI) in hyperkinetic movement disorders (HMD). We additionally discuss alterations from…
  • 2022 International Congress

    The reasons for referral to a Parkinson’s Clinical Psychology service

    R. Lewis-Morton, B. Mohamed, E. Thomas, S. Mahon, T. Williams (Cardiff, United Kingdom)

    Objective: To understand the reasons for referral to a Parkinson's Clinical Psychology service. Background: In recent times, the psychological impact of Parkinson’s Disease has become…
  • 2022 International Congress

    Reported Clinical and Quality-of-Life Outcomes With 24-Hour Levodopa-Carbidopa Intestinal Gel Administration Compared With 16-Hour Administration

    N. Kovács, M. Simu, O. Sanchez Soliño, J. Parra, J. Alcazar, S. Snedecor, V. Fung (Pécs, Hungary)

    Objective: To evaluate any existing differences between the reported outcomes in patients with advanced Parkinson’s disease (APD) using continuous 16-hour (hr) infusions of levodopa-carbidopa intestinal…
  • 2022 International Congress

    Apomorphine Sublingual Film Versus Subcutaneous Apomorphine in the Treatment of OFF Episodes in Parkinson’s Disease: Results From an Assessment of Patient Satisfaction

    J. Schwarz, C. Carroll, G. Ebersbach, J. Kulisevsky, A. Tessitore, I. Zhang, A. Bowling, S. Wu, E. Pappert, A. Thach (Oberbayern, Germany)

    Objective: Evaluate treatment satisfaction with apomorphine sublingual film (SL-APO) vs subcutaneous apomorphine (SC-APO) for the treatment of OFF episodes in patients with Parkinson’s disease (PD).…
  • 2022 International Congress

    Widening the phenotype of FXTAS in females: Spasmodic dysphonia in two patients

    S. Khan, S. Williams, J. Cosgrove, J. Bamford, J. Alty (Leeds, United Kingdom)

    Objective: We present the cases of two female FXTAS patients who both developed spasmodic dysphonia (SD), also known as laryngeal dystonia. Background: Fragile-X-associated tremor/ataxia syndrome…
  • 2022 International Congress

    Changes in botulinum toxin dosing in cervical dystonia over 7 years

    S. Rafee, M. Hutchinson (Dublin, Ireland)

    Objective: To assess changes in botulinum toxin dosing over the course of illness of cervical dystonia. Background: Muscle specific botulinum toxin injections remains the main…
  • « Previous Page
  • 1
  • …
  • 43
  • 44
  • 45
  • 46
  • 47
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley